ArticleTranslational pediatrics2024

Will nirsevimab be the holy grail for prevention of respiratory syncytial virus lower respiratory tract infections in infants?

Nusrat HomairaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.